199 related articles for article (PubMed ID: 21078522)
21. Insulin-like growth factor system gene expression in human endometrium during the menstrual cycle.
Zhou J; Dsupin BA; Giudice LC; Bondy CA
J Clin Endocrinol Metab; 1994 Dec; 79(6):1723-34. PubMed ID: 7527408
[TBL] [Abstract][Full Text] [Related]
22. Gene expression and serum levels of insulin-like growth factors (IGFs) and IGF-binding proteins in a case of non-islet cell tumour hypoglycaemia.
Holt RI; Teale JD; Jones JS; Quin JD; McGregor AM; Miell JP
Growth Horm IGF Res; 1998 Dec; 8(6):447-54. PubMed ID: 10985756
[TBL] [Abstract][Full Text] [Related]
23. Genetic variability in IGF-1 and IGFBP-3 and body size in early life.
Poole EM; Tworoger SS; Hankinson SE; Baer HJ
BMC Public Health; 2012 Aug; 12():659. PubMed ID: 22894543
[TBL] [Abstract][Full Text] [Related]
24. Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study.
Tamimi RM; Cox DG; Kraft P; Pollak MN; Haiman CA; Cheng I; Freedman ML; Hankinson SE; Hunter DJ; Colditz GA
Breast Cancer Res; 2007; 9(1):R18. PubMed ID: 17300730
[TBL] [Abstract][Full Text] [Related]
25. mRNA expression of insulin-like growth factor-I (IGF-I) is suppressed and those of IGF-II and IGF-binding protein-1 are constantly expressed in the endometrium during use of an intrauterine levonorgestrel system.
Rutanen EM; Salmi A; Nyman T
Mol Hum Reprod; 1997 Sep; 3(9):749-54. PubMed ID: 9357999
[TBL] [Abstract][Full Text] [Related]
26. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
[TBL] [Abstract][Full Text] [Related]
27. Abnormal IGF-Binding Protein Profile in the Bone Marrow of Multiple Myeloma Patients.
Bieghs L; Brohus M; Kristensen IB; Abildgaard N; Bøgsted M; Johnsen HE; Conover CA; De Bruyne E; Vanderkerken K; Overgaard MT; Nyegaard M
PLoS One; 2016; 11(4):e0154256. PubMed ID: 27111220
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study.
Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Rinaldi S; Landi S; Boillot C; Monnier S; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Ardanaz E; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
Br J Cancer; 2006 Jan; 94(2):299-307. PubMed ID: 16404426
[TBL] [Abstract][Full Text] [Related]
29. Association between components of the insulin-like growth factor system and endometrial cancer risk.
Augustin LS; Dal Maso L; Franceschi S; Talamini R; Kendall CW; Jenkins DJ; Vidgen E; La Vecchia C
Oncology; 2004; 67(1):54-9. PubMed ID: 15459496
[TBL] [Abstract][Full Text] [Related]
30. Expression levels of mRNA for insulin-like growth factors 1 and 2, IGF receptors and IGF binding proteins in in vivo and in vitro grown bovine follicles.
Rebouças EL; Costa JJ; Passos MJ; Silva AW; Rossi RO; van den Hurk R; Silva JR
Zygote; 2014 Nov; 22(4):521-32. PubMed ID: 23659735
[TBL] [Abstract][Full Text] [Related]
31. Influence of polymorphisms in genes encoding for insulin-like growth factor (IGF)-I, insulin, and IGF-binding protein (IGFBP)-3 on IGF-I, IGF-II, and IGFBP-3 levels in umbilical cord plasma.
Landmann E; Kollerits B; Kreuder JG; Blum WF; Kronenberg F; Rudloff S
Horm Res Paediatr; 2012; 77(6):341-50. PubMed ID: 22739332
[TBL] [Abstract][Full Text] [Related]
32. IGFBP1 and IGFBP3 polymorphisms predict circulating IGFBP-3 levels among women from high-risk breast cancer families.
Rosendahl AH; Hietala M; Henningson M; Olsson H; Jernström H
Breast Cancer Res Treat; 2011 Jun; 127(3):785-94. PubMed ID: 21140206
[TBL] [Abstract][Full Text] [Related]
33. Growth hormone-binding protein is directly and IGFBP-3 is inversely associated with risk of female breast cancer.
Pazaitou-Panayiotou K; Kelesidis T; Kelesidis I; Kaprara A; Blakeman J; Vainas I; Mpousoulegas A; Williams CJ; Mantzoros C
Eur J Endocrinol; 2007 Feb; 156(2):187-94. PubMed ID: 17287408
[TBL] [Abstract][Full Text] [Related]
34. Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer.
Lukanova A; Zeleniuch-Jacquotte A; Lundin E; Micheli A; Arslan AA; Rinaldi S; Muti P; Lenner P; Koenig KL; Biessy C; Krogh V; Riboli E; Shore RE; Stattin P; Berrino F; Hallmans G; Toniolo P; Kaaks R
Int J Cancer; 2004 Jan; 108(2):262-8. PubMed ID: 14639613
[TBL] [Abstract][Full Text] [Related]
35. Insulin-like growth factors and prostate cancer: a population-based case-control study in China.
Chokkalingam AP; Pollak M; Fillmore CM; Gao YT; Stanczyk FZ; Deng J; Sesterhenn IA; Mostofi FK; Fears TR; Madigan MP; Ziegler RG; Fraumeni JF; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):421-7. PubMed ID: 11352850
[TBL] [Abstract][Full Text] [Related]
36. Serum levels of insulin-like growth factor-I, IGF-binding protein 1 and 3, and insulin and endometrial cancer risk.
Weiderpass E; Brismar K; Bellocco R; Vainio H; Kaaks R
Br J Cancer; 2003 Nov; 89(9):1697-704. PubMed ID: 14583772
[TBL] [Abstract][Full Text] [Related]
37. Protein QTL analysis of IGF-I and its binding proteins provides insights into growth biology.
Bartell E; Fujimoto M; Khoury JC; Khoury PR; Vedantam S; Astley CM; Hirschhorn JN; Dauber A
Hum Mol Genet; 2020 Aug; 29(15):2625-2636. PubMed ID: 32484228
[TBL] [Abstract][Full Text] [Related]
38. Common genetic variation of insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, and acid labile subunit in relation to serum IGF-I levels and mammographic density.
Taverne CW; Verheus M; McKay JD; Kaaks R; Canzian F; Grobbee DE; Peeters PH; van Gils CH
Breast Cancer Res Treat; 2010 Oct; 123(3):843-55. PubMed ID: 20155489
[TBL] [Abstract][Full Text] [Related]
39. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911
[TBL] [Abstract][Full Text] [Related]
40. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.
Stattin P; Bylund A; Rinaldi S; Biessy C; Déchaud H; Stenman UH; Egevad L; Riboli E; Hallmans G; Kaaks R
J Natl Cancer Inst; 2000 Dec; 92(23):1910-7. PubMed ID: 11106682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
